Across TCGA pan-cancer cohorts, LINC01709 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01709’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01709 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01709 is over-expressed in tumor.
COAD are the cancer types where LINC01709 tumor–normal differential expression is most reproducible.